Toolkit/Boolean logic gate

Boolean logic gate

Construct Pattern·Research·Since 2024

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

The Boolean logic gate is a construct pattern incorporated into a photoactivatable CRISPR/Cas9-inducible DNAzyme probe. In the reported system, it contributed to superior spatiotemporal control for dynamic imaging of nuclear Zn2+ in HeLa cells and mice.

Usefulness & Problems

Why this is useful

This construct pattern is useful for tightening conditional control over probe activation in a light-responsive CRISPR-DNAzyme imaging system. The reported implementation enabled in situ imaging of nuclear Zn2+ in living cells and improved spatiotemporal control during dynamic monitoring.

Source:

With this design, the CRISPR/Cas9‐inducible imaging of nuclear Zn 2+ is demonstrated in living cells.

Problem solved

It addresses the problem of achieving precise spatiotemporal activation of a DNAzyme-based imaging probe in the nucleus. In the cited design, Boolean logic gating was combined with photoactivation and CRISPR/Cas9-triggered probe conversion to reduce premature activity and support controlled nuclear Zn2+ imaging.

Source:

With this design, the CRISPR/Cas9‐inducible imaging of nuclear Zn 2+ is demonstrated in living cells.

Problem links

Need controllable genome or transcript editing

Derived

The Boolean logic gate is a construct pattern incorporated into a photoactivatable CRISPR/Cas9-inducible DNAzyme probe. In the reported system, it contributed to superior spatiotemporal control for dynamic imaging of nuclear Zn2+ in HeLa cells and mice.

Need precise spatiotemporal control with light input

Derived

The Boolean logic gate is a construct pattern incorporated into a photoactivatable CRISPR/Cas9-inducible DNAzyme probe. In the reported system, it contributed to superior spatiotemporal control for dynamic imaging of nuclear Zn2+ in HeLa cells and mice.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A reusable architecture pattern for arranging parts into an engineered system.

Techniques

No technique tags yet.

Target processes

editing

Input: Light

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: spectral hardware requirementoperating role: regulator

The reported probe is a three-stranded DNAzyme construct containing a 20-bp CRISPR/Cas9 recognition site that blocks DNAzyme activity until Cas9/sgRNA cleavage generates the catalytic DNAzyme structure in the nucleus. The system was integrated with a photoactivation strategy and applied in HeLa cells and mice, but the supplied evidence does not detail the photochemical cage, illumination wavelength, or delivery format.

The available evidence describes Boolean logic gate integration at a high level but does not specify the exact logical architecture, inputs, or truth table. Quantitative performance metrics, generalizability beyond nuclear Zn2+ imaging, and independent replication are not provided in the supplied evidence.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1application capabilitysupports2024Source 1needs review

The CRISPR/Cas9-inducible DNAzyme design enables in situ imaging of nuclear Zn2+ in living cells.

With this design, the CRISPR/Cas9‐inducible imaging of nuclear Zn 2+ is demonstrated in living cells.
Claim 2application capabilitysupports2024Source 1needs review

The CRISPR/Cas9-inducible DNAzyme design enables in situ imaging of nuclear Zn2+ in living cells.

With this design, the CRISPR/Cas9‐inducible imaging of nuclear Zn 2+ is demonstrated in living cells.
Claim 3application capabilitysupports2024Source 1needs review

The CRISPR/Cas9-inducible DNAzyme design enables in situ imaging of nuclear Zn2+ in living cells.

With this design, the CRISPR/Cas9‐inducible imaging of nuclear Zn 2+ is demonstrated in living cells.
Claim 4application capabilitysupports2024Source 1needs review

The CRISPR/Cas9-inducible DNAzyme design enables in situ imaging of nuclear Zn2+ in living cells.

With this design, the CRISPR/Cas9‐inducible imaging of nuclear Zn 2+ is demonstrated in living cells.
Claim 5application capabilitysupports2024Source 1needs review

The CRISPR/Cas9-inducible DNAzyme design enables in situ imaging of nuclear Zn2+ in living cells.

With this design, the CRISPR/Cas9‐inducible imaging of nuclear Zn 2+ is demonstrated in living cells.
Claim 6application capabilitysupports2024Source 1needs review

The CRISPR/Cas9-inducible DNAzyme design enables in situ imaging of nuclear Zn2+ in living cells.

With this design, the CRISPR/Cas9‐inducible imaging of nuclear Zn 2+ is demonstrated in living cells.
Claim 7application capabilitysupports2024Source 1needs review

The CRISPR/Cas9-inducible DNAzyme design enables in situ imaging of nuclear Zn2+ in living cells.

With this design, the CRISPR/Cas9‐inducible imaging of nuclear Zn 2+ is demonstrated in living cells.
Claim 8comparative performancesupports2024Source 1needs review

Integrating the CRISPR-DNAzyme system with photoactivation strategy and Boolean logic gate provided superior spatiotemporal control imaging for dynamic monitoring of nuclear Zn2+ in HeLa cells and mice.

Moreover, the superiority of CRISPR‐DNAzyme for spatiotemporal control imaging was demonstrated by integrating it with photoactivation strategy and Boolean logic gate for dynamic monitoring nuclear Zn 2+ in both HeLa cells and mice.
Claim 9comparative performancesupports2024Source 1needs review

Integrating the CRISPR-DNAzyme system with photoactivation strategy and Boolean logic gate provided superior spatiotemporal control imaging for dynamic monitoring of nuclear Zn2+ in HeLa cells and mice.

Moreover, the superiority of CRISPR‐DNAzyme for spatiotemporal control imaging was demonstrated by integrating it with photoactivation strategy and Boolean logic gate for dynamic monitoring nuclear Zn 2+ in both HeLa cells and mice.
Claim 10comparative performancesupports2024Source 1needs review

Integrating the CRISPR-DNAzyme system with photoactivation strategy and Boolean logic gate provided superior spatiotemporal control imaging for dynamic monitoring of nuclear Zn2+ in HeLa cells and mice.

Moreover, the superiority of CRISPR‐DNAzyme for spatiotemporal control imaging was demonstrated by integrating it with photoactivation strategy and Boolean logic gate for dynamic monitoring nuclear Zn 2+ in both HeLa cells and mice.
Claim 11comparative performancesupports2024Source 1needs review

Integrating the CRISPR-DNAzyme system with photoactivation strategy and Boolean logic gate provided superior spatiotemporal control imaging for dynamic monitoring of nuclear Zn2+ in HeLa cells and mice.

Moreover, the superiority of CRISPR‐DNAzyme for spatiotemporal control imaging was demonstrated by integrating it with photoactivation strategy and Boolean logic gate for dynamic monitoring nuclear Zn 2+ in both HeLa cells and mice.
Claim 12comparative performancesupports2024Source 1needs review

Integrating the CRISPR-DNAzyme system with photoactivation strategy and Boolean logic gate provided superior spatiotemporal control imaging for dynamic monitoring of nuclear Zn2+ in HeLa cells and mice.

Moreover, the superiority of CRISPR‐DNAzyme for spatiotemporal control imaging was demonstrated by integrating it with photoactivation strategy and Boolean logic gate for dynamic monitoring nuclear Zn 2+ in both HeLa cells and mice.
Claim 13comparative performancesupports2024Source 1needs review

Integrating the CRISPR-DNAzyme system with photoactivation strategy and Boolean logic gate provided superior spatiotemporal control imaging for dynamic monitoring of nuclear Zn2+ in HeLa cells and mice.

Moreover, the superiority of CRISPR‐DNAzyme for spatiotemporal control imaging was demonstrated by integrating it with photoactivation strategy and Boolean logic gate for dynamic monitoring nuclear Zn 2+ in both HeLa cells and mice.
Claim 14comparative performancesupports2024Source 1needs review

Integrating the CRISPR-DNAzyme system with photoactivation strategy and Boolean logic gate provided superior spatiotemporal control imaging for dynamic monitoring of nuclear Zn2+ in HeLa cells and mice.

Moreover, the superiority of CRISPR‐DNAzyme for spatiotemporal control imaging was demonstrated by integrating it with photoactivation strategy and Boolean logic gate for dynamic monitoring nuclear Zn 2+ in both HeLa cells and mice.
Claim 15design mechanismsupports2024Source 1needs review

The three-stranded DNAzyme probe contains a 20-bp CRISPR/Cas9 recognition site that blocks DNAzyme activity until Cas9/sgRNA cleavage forms the catalytic DNAzyme structure in the nucleus.

We developed a three‐stranded DNAzyme probe (TSDP) that contained a 20‐base‐pair (20‐bp) recognition site of a CRISPR/Cas9, which blocks the DNAzyme activity. When Cas9, with its specialized nuclear localization function, forms an active complex with sgRNA within the cell nucleus, it cleaves the TSDP at the recognition site, resulting in the in situ formation of catalytic DNAzyme structure.
recognition site length 20 bp
Claim 16design mechanismsupports2024Source 1needs review

The three-stranded DNAzyme probe contains a 20-bp CRISPR/Cas9 recognition site that blocks DNAzyme activity until Cas9/sgRNA cleavage forms the catalytic DNAzyme structure in the nucleus.

We developed a three‐stranded DNAzyme probe (TSDP) that contained a 20‐base‐pair (20‐bp) recognition site of a CRISPR/Cas9, which blocks the DNAzyme activity. When Cas9, with its specialized nuclear localization function, forms an active complex with sgRNA within the cell nucleus, it cleaves the TSDP at the recognition site, resulting in the in situ formation of catalytic DNAzyme structure.
recognition site length 20 bp
Claim 17design mechanismsupports2024Source 1needs review

The three-stranded DNAzyme probe contains a 20-bp CRISPR/Cas9 recognition site that blocks DNAzyme activity until Cas9/sgRNA cleavage forms the catalytic DNAzyme structure in the nucleus.

We developed a three‐stranded DNAzyme probe (TSDP) that contained a 20‐base‐pair (20‐bp) recognition site of a CRISPR/Cas9, which blocks the DNAzyme activity. When Cas9, with its specialized nuclear localization function, forms an active complex with sgRNA within the cell nucleus, it cleaves the TSDP at the recognition site, resulting in the in situ formation of catalytic DNAzyme structure.
recognition site length 20 bp
Claim 18design mechanismsupports2024Source 1needs review

The three-stranded DNAzyme probe contains a 20-bp CRISPR/Cas9 recognition site that blocks DNAzyme activity until Cas9/sgRNA cleavage forms the catalytic DNAzyme structure in the nucleus.

We developed a three‐stranded DNAzyme probe (TSDP) that contained a 20‐base‐pair (20‐bp) recognition site of a CRISPR/Cas9, which blocks the DNAzyme activity. When Cas9, with its specialized nuclear localization function, forms an active complex with sgRNA within the cell nucleus, it cleaves the TSDP at the recognition site, resulting in the in situ formation of catalytic DNAzyme structure.
recognition site length 20 bp
Claim 19design mechanismsupports2024Source 1needs review

The three-stranded DNAzyme probe contains a 20-bp CRISPR/Cas9 recognition site that blocks DNAzyme activity until Cas9/sgRNA cleavage forms the catalytic DNAzyme structure in the nucleus.

We developed a three‐stranded DNAzyme probe (TSDP) that contained a 20‐base‐pair (20‐bp) recognition site of a CRISPR/Cas9, which blocks the DNAzyme activity. When Cas9, with its specialized nuclear localization function, forms an active complex with sgRNA within the cell nucleus, it cleaves the TSDP at the recognition site, resulting in the in situ formation of catalytic DNAzyme structure.
recognition site length 20 bp
Claim 20design mechanismsupports2024Source 1needs review

The three-stranded DNAzyme probe contains a 20-bp CRISPR/Cas9 recognition site that blocks DNAzyme activity until Cas9/sgRNA cleavage forms the catalytic DNAzyme structure in the nucleus.

We developed a three‐stranded DNAzyme probe (TSDP) that contained a 20‐base‐pair (20‐bp) recognition site of a CRISPR/Cas9, which blocks the DNAzyme activity. When Cas9, with its specialized nuclear localization function, forms an active complex with sgRNA within the cell nucleus, it cleaves the TSDP at the recognition site, resulting in the in situ formation of catalytic DNAzyme structure.
recognition site length 20 bp
Claim 21design mechanismsupports2024Source 1needs review

The three-stranded DNAzyme probe contains a 20-bp CRISPR/Cas9 recognition site that blocks DNAzyme activity until Cas9/sgRNA cleavage forms the catalytic DNAzyme structure in the nucleus.

We developed a three‐stranded DNAzyme probe (TSDP) that contained a 20‐base‐pair (20‐bp) recognition site of a CRISPR/Cas9, which blocks the DNAzyme activity. When Cas9, with its specialized nuclear localization function, forms an active complex with sgRNA within the cell nucleus, it cleaves the TSDP at the recognition site, resulting in the in situ formation of catalytic DNAzyme structure.
recognition site length 20 bp
Claim 22toolbox expansionsupports2024Source 1needs review

This conceptual design expands the DNAzyme toolbox for visualizing nuclear metal ions and provides new analytical methods for nuclear metal-associated biology.

Collectively, this conceptual design expands the DNAzyme toolbox for visualizing nuclear metal ions and thus provides new analytical methods for nuclear metal‐associated biology.
Claim 23toolbox expansionsupports2024Source 1needs review

This conceptual design expands the DNAzyme toolbox for visualizing nuclear metal ions and provides new analytical methods for nuclear metal-associated biology.

Collectively, this conceptual design expands the DNAzyme toolbox for visualizing nuclear metal ions and thus provides new analytical methods for nuclear metal‐associated biology.
Claim 24toolbox expansionsupports2024Source 1needs review

This conceptual design expands the DNAzyme toolbox for visualizing nuclear metal ions and provides new analytical methods for nuclear metal-associated biology.

Collectively, this conceptual design expands the DNAzyme toolbox for visualizing nuclear metal ions and thus provides new analytical methods for nuclear metal‐associated biology.
Claim 25toolbox expansionsupports2024Source 1needs review

This conceptual design expands the DNAzyme toolbox for visualizing nuclear metal ions and provides new analytical methods for nuclear metal-associated biology.

Collectively, this conceptual design expands the DNAzyme toolbox for visualizing nuclear metal ions and thus provides new analytical methods for nuclear metal‐associated biology.
Claim 26toolbox expansionsupports2024Source 1needs review

This conceptual design expands the DNAzyme toolbox for visualizing nuclear metal ions and provides new analytical methods for nuclear metal-associated biology.

Collectively, this conceptual design expands the DNAzyme toolbox for visualizing nuclear metal ions and thus provides new analytical methods for nuclear metal‐associated biology.
Claim 27toolbox expansionsupports2024Source 1needs review

This conceptual design expands the DNAzyme toolbox for visualizing nuclear metal ions and provides new analytical methods for nuclear metal-associated biology.

Collectively, this conceptual design expands the DNAzyme toolbox for visualizing nuclear metal ions and thus provides new analytical methods for nuclear metal‐associated biology.
Claim 28toolbox expansionsupports2024Source 1needs review

This conceptual design expands the DNAzyme toolbox for visualizing nuclear metal ions and provides new analytical methods for nuclear metal-associated biology.

Collectively, this conceptual design expands the DNAzyme toolbox for visualizing nuclear metal ions and thus provides new analytical methods for nuclear metal‐associated biology.

Approval Evidence

1 source1 linked approval claimfirst-pass slug boolean-logic-gate
the superiority of CRISPR‐DNAzyme for spatiotemporal control imaging was demonstrated by integrating it with photoactivation strategy and Boolean logic gate

Source:

comparative performancesupports

Integrating the CRISPR-DNAzyme system with photoactivation strategy and Boolean logic gate provided superior spatiotemporal control imaging for dynamic monitoring of nuclear Zn2+ in HeLa cells and mice.

Moreover, the superiority of CRISPR‐DNAzyme for spatiotemporal control imaging was demonstrated by integrating it with photoactivation strategy and Boolean logic gate for dynamic monitoring nuclear Zn 2+ in both HeLa cells and mice.

Source:

Comparisons

Source-backed strengths

The integrated system was reported to provide superior spatiotemporal control imaging when Boolean logic gating was combined with photoactivation and the CRISPR-DNAzyme design. The platform was demonstrated for dynamic monitoring of nuclear Zn2+ in HeLa cells and mice, indicating validation in both cultured cells and an in vivo context.

Source:

Moreover, the superiority of CRISPR‐DNAzyme for spatiotemporal control imaging was demonstrated by integrating it with photoactivation strategy and Boolean logic gate for dynamic monitoring nuclear Zn 2+ in both HeLa cells and mice.

Compared with retinal prostheses

Boolean logic gate and retinal prostheses address a similar problem space because they share editing.

Shared frame: same top-level item type; shared target processes: editing; same primary input modality: light

Strengths here: looks easier to implement in practice; may avoid an exogenous cofactor requirement.

Boolean logic gate and three-stranded DNAzyme probe address a similar problem space because they share editing.

Shared frame: same top-level item type; shared target processes: editing; shared mechanisms: boolean logic gating, crispr/cas9-mediated cleavage

Relative tradeoffs: looks easier to implement in practice.

Boolean logic gate and tube-in-tube structure address a similar problem space because they share editing.

Shared frame: same top-level item type; shared target processes: editing; shared mechanisms: photoactivation; same primary input modality: light

Ranked Citations

  1. 1.
    StructuralSource 1Angewandte Chemie2024Claim 1Claim 2Claim 3

    Extracted from this source document.